OSSIO logo — Only Nature Remains.

OSSIO

Only Nature Remains.

Founded 2014 United States Woburn, United States 108 employees Series C Total: $60.50M Medical Devices

General Information

Company Name OSSIO
Founded Year 2014
Location United States Woburn, United States +2
Founders / Decision Makers
Team member Team member
Employees 108
Industries Medical Devices
Funding Stage Series C
Social

Get notified when OSSIO moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OSSIO

OSSIO is an orthopedic medical device company with the slogan "Only Nature Remains." Founded in Israel in 2014, the company aims to revolutionize the orthopedic experience for physicians, patients, and payors. Their mission is to disrupt the $10B+ orthopedic fixation market by replacing metal implants with an intelligent bone regeneration technology. Ossio's OSSIOfiber™ represents a breakthrough material platform for orthopedic and podiatric surgeons, offering a more biologically friendly way to restore mobility with nothing permanent left behind. The products provide the necessary mechanical strength for easy insertion and secure fixation while enabling the body to regrow bone, completely incorporating and replacing the implant without adverse inflammation and weakness often seen in "bio-resorbables." The company is headquartered in the United States, and their latest investment was a $38.50M Series C investment from MVM Partners on 17 October 2022.

Taxonomy: orthopedic medical devices, intelligent bone regeneration technology, orthopedic fixation market, OSSIOfiber, biologically friendly implants, orthopedic surgeons, podiatric surgeons, biomechanical research, non-permanent fixation, bio-integrative hardware, biocompatible implants, biological bone healing, implant materials, medical device innovation, orthopedic implant technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 1 •••• •••• 17 Oct 2022
Series A •••••• 4
Investor Investor Investor
•••• ••••
11 Mar 2019
Seed Round •••••• 1
Investor
01 May 2016

OSSIO Alternatives & Competitors

OSSIO vs

Innovative solutions for orthopedic care, delivering minimally invasive devices to practitioners wor...

Seed
Biotechnology, Health Care
OSSIO vs
Leith Medical, Inc
Leith Medical, Inc United States

Patented One Screw, One Step™ Foot & Ankle Plating System with Anti-Backout Technology

4 employees
Health Care, Medical Devices
OSSIO vs

Bringing Bones Together

Series Unknown
11 employees
Health Care, Manufacturing

FAQ About OSSIO

Only Nature Remains.
OSSIO was founded in 2014.
OSSIO is headquartered in Woburn, United States.
OSSIO operates in the following industries: Medical Devices.
OSSIO has approximately 108 employees.
OSSIO has completed 3 funding rounds, raising a total of $60.50M. The latest funding stage is Series C.
Top alternatives and competitors to OSSIO include Nutek Orthopaedics, Leith Medical, Inc, Metric Medical Devices, Inc., NEXILIS AG, INNOTERE GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OSSIO and Nutek Orthopaedics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OSSIO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy